Delta GREENS Food is Medicine Intervention
Launched by TUFTS UNIVERSITY · Apr 8, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Delta GREENS Food is Medicine Intervention is a clinical trial aimed at improving health in communities in Mississippi, particularly focusing on people with conditions like obesity, diabetes, and high blood pressure. The project is designed to help residents of Bolivar, Washington, and Sunflower counties, where many people face challenges like poverty and food insecurity. Participants in this trial will receive boxes of fresh fruits and vegetables, along with educational materials about nutrition. The goal is to see if this support can lead to better health outcomes for those who are at risk for chronic health issues.
To be eligible for this study, participants should be patients at the Delta Health Center clinics, have a body mass index (BMI) of 25 or higher, and have a specific range of blood sugar levels. However, those with certain health conditions, such as type 1 diabetes or severe heart disease, cannot participate. If you join the study, you will receive regular deliveries of produce and nutrition education while helping researchers understand the impact of this program. This trial is not only about improving individual health but also hopes to create a model that can be used in other communities facing similar challenges across the country.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient at participating Delta Health Center (DHC) clinics
- • BMI: ≥ 25
- • Hemoglobin A1C (HbA1c): \>5.7 to 8.5%, inclusive
- Exclusion Criteria:
- • Type 1 diabetes
- • Current use of incretin agonists (e.g., semaglutide, dulaglutide, liraglutide)
- * Uncontrolled hypertension:
- • Systolic blood pressure \> 160 mmHg
- • Diastolic blood pressure \> 100 mmHg
- • Severe symptomatic cardiovascular disease
- * Recent (6 months) history of:
- • Myocardial infarction
- • Percutaneous coronary intervention
- • Coronary artery bypass graft
- • Cerebrovascular disease
- • Participant in diabetes, nutrition, or weight intervention research in the last 12 months
- • Another family member or household member is a study participant
- • History of bariatric surgery or considering bariatric surgery in the next year or prior bariatric surgery
- • Lack of safe, stable residence and ability to store produce
- • Lack of telephone
- • Pregnancy/breastfeeding or intended pregnancy in the next year
- • Drug or alcohol misuse that would impair the ability to complete study activities
- • Known psychosis or major psychiatric illness that prevents participation in study activities
- • Any other reason that in the investigators' best judgment places the participants at risk or increases likelihood of poor adherence
About Tufts University
Tufts University is a prestigious research institution renowned for its commitment to advancing health and medicine through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Tufts leverages its expertise in biomedical research, public health, and clinical practice to design and conduct rigorous studies that address critical health challenges. The university's clinical trial programs are characterized by their adherence to high ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing valuable insights to the scientific community. Through its dedication to fostering education and research, Tufts University plays a vital role in translating findings into effective health interventions and policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Christina D Economos, PhD
Principal Investigator
Tufts University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported